Significant Ownership of Lind Global Fund II LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Lind Global Fund II LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton - Jeff Easton, Managing Member
Manager location
New York, NY

Follow Filing Activity

Follow Lind Global Fund II LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of Lind Global Fund II LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PXMD PaxMedica, Inc. Common Stock, par value $0.0001 per share 9.9% $29,550 985,000 Lind Global Fund II LP 31 Dec 2024
AUMN Golden Minerals Co Common Stock, $0.01 par value per share 8.7% $314,286 1,428,572 Lind Global Fund II LP 30 Jun 2025
NCPL Netcapital Inc. Common Stock, par value $0.001 per share 4.9% $226,609 -$180,416 112,741 -44% Lind Global Fund II LP 31 Mar 2025
SNES SenesTech, Inc. Common Stock, par value $0.001 per share 4.9% $208,215 -$41,545 93,370 -17% Lind Global Fund II LP 31 Mar 2025
NLSP NLS Pharmaceuticals Ltd. Common Shares, par value CHF 0.02 per share 4.9% $90,866 59,780 Lind Global Fund II LP 31 Dec 2024
ABVC ABVC BIOPHARMA, INC. Common Stock, par value $0.001 per share 3.2% $2,211,858 -$3,048,392 557,143 -58% Lind Global Fund II LP 30 Jun 2025
SINT SINTX Technologies, Inc. Common Stock, par value $0.01 per share 2.8% $174,470 73,000 0% Lind Global Fund II LP 31 Mar 2025
LFWD Lifeward Ltd. Ordinary shares, par value NIS 1.75 1.7% 182,265 -81% Lind Global Fund II LP 31 Mar 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 0.78% $3,029,101 -$3,590,400 202,480 -54% Lind Global Fund II LP 31 Mar 2026
WBUYF WEBUY GLOBAL LTD Class A Ordinary Shares, par value $0.000000385 per share 0% $11.36 -$206,770 284 -100% Lind Global Fund II LP 30 Jun 2025
SEELQ SEELOS THERAPEUTICS, INC. Common Stock, par value $0.001 per share 0% $0 0 Lind Global Fund II LP 31 Dec 2024
GVP GSE SYSTEMS INC Common Stock, par value $0.01 per share 0% $0 0 Lind Global Fund II LP 31 Dec 2024

Schedules 13D/G Reported by Lind Global Fund II LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .